Partner With Us

Following huge investment in the PD-1 CTLA-4 space, the next generation of ICI is already showing great therapeutic promise and rapid investment in TIGIT has been seen from biopharma leaders.

As TIGIT research efforts are scaled, senior decision makers are actively seeking partners with reliable and scientifically robust solutions to pre-clinical models, companion diagnostics, biomarker platforms as well as CRO partners.

Email to learn more.

This is your opportunity to:

ttigit_-_monthly_touchpoints (1)

Touch base with
the industry to
stay updated on
key advances and
maintain lasting


Join the conversation
to better understand
industry challenges
and develop your
solutions early, as
the industry demand


Demonstrate your
expertise with 1:1
networking and
working groups to
secure new business
in this early, rapidly
growing space